New data reveal that 4 out of 5 breast cancer patients eligible for genomic testing are not told it is available to them
November 21, 2022 02:00 ET
|
Cancer Patients Europe
Brussels, Nov. 21, 2022 (GLOBE NEWSWIRE) -- If you were diagnosed with cancer, you would hope you were being given the chance to benefit from the latest advances in the field of oncology. However,...
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Genomic Health, Inc. (NASDAQ: GHDX) on Behalf of Genomic Shareholders and Encourages Genomic Investors to Contact the Firm
July 29, 2019 16:08 ET
|
Bragar Eagel & Squire
NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Genomic Health, Inc. (NASDAQ: GHDX) on behalf of...
Todos Medical Enters Into Definitive Agreement With Orot+ for Exclusive Distribution Rights of its Breast Cancer Screening Tests in 2 European Countries
April 15, 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, April 15, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection...
JEFFREY THOMAS ELLIOTT, CFA Joins Exagen’s Board of Directors
March 26, 2019 08:45 ET
|
Exagen Diagnostics, Inc.
San Diego, CA and Albuquerque, NM, March 26, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
Todos Medical reports on results of clinical trials for its blood test for breast cancer screening (TM - B1) conducted at Kaplan Hospital in Rehovot, Israel
March 22, 2018 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, March 22, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTC Pink:TOMDF) (http://www.Todosmedical.com) today announced the results of a clinical trial recently completed at Kaplan...
3 Winners Declared in 2nd Value Investing Challenge Buyside Research Contest
August 30, 2013 09:00 ET
|
SumZero, Inc.; The Value Investing Congress
NEW YORK, NY--(Marketwired - Aug 30, 2013) - SumZero, Inc. and The Value Investing Congress today announced the three winners in their annual competition designed to test the research skills of...